Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Marshall

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Protein Expression and Purification|August 31, 2023
Biochemical and biophysical characterization of the RAS family small GTPase protein DiRAS3Takashi Saitoh, Ha-Neul Kim, Riku Narita, et al.
Journal of Biomolecular NMR|August 18, 2020
NMR in integrated biophysical drug discovery for RAS: past, present, and futureChristopher B Marshall, Fenneke KleinJan, Teklab Gebregiworgis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding siteMohammad T Mazhab-Jafari, Christopher B Marshall, Matthew J Smith, et al.
The Journal of Biological Chemistry|May 27, 2016
Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1)Zhenhao Fang, Christopher B Marshall, Jiani C Yin, et al.
The Journal of Cell Biology|August 18, 2019
Spatiotemporal dynamics of GEF-H1 activation controlled by microtubule- and Src-mediated pathwaysMihai L Azoitei, Jungsik Noh, Daniel J Marston, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase InhibitorsKu-Geng Huo, Hirotsugu Notsuda, Zhenhao Fang, et al.
Science Signaling|November 2, 2017
MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarityMaría-José Sandí, Christopher B Marshall, Marc Balan, et al.
Cancer Cell|February 15, 2014
The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1Jane Cullis, David Meiri, Maria Jose Sandi, et al.
Iscience|November 17, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumorsJoshua P Gray, Gamze Bildik, Ha-Neul Kim, et al.
Nature Communications|January 16, 2019
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformationYoshihito Kano, Teklab Gebregiworgis, Christopher B Marshall, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Protein Expression and Purification|August 31, 2023
Biochemical and biophysical characterization of the RAS family small GTPase protein DiRAS3Takashi Saitoh, Ha-Neul Kim, Riku Narita, et al.
Journal of Biomolecular NMR|August 18, 2020
NMR in integrated biophysical drug discovery for RAS: past, present, and futureChristopher B Marshall, Fenneke KleinJan, Teklab Gebregiworgis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding siteMohammad T Mazhab-Jafari, Christopher B Marshall, Matthew J Smith, et al.
The Journal of Biological Chemistry|May 27, 2016
Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1)Zhenhao Fang, Christopher B Marshall, Jiani C Yin, et al.
The Journal of Cell Biology|August 18, 2019
Spatiotemporal dynamics of GEF-H1 activation controlled by microtubule- and Src-mediated pathwaysMihai L Azoitei, Jungsik Noh, Daniel J Marston, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase InhibitorsKu-Geng Huo, Hirotsugu Notsuda, Zhenhao Fang, et al.
Science Signaling|November 2, 2017
MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarityMaría-José Sandí, Christopher B Marshall, Marc Balan, et al.
Cancer Cell|February 15, 2014
The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1Jane Cullis, David Meiri, Maria Jose Sandi, et al.
Iscience|November 17, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumorsJoshua P Gray, Gamze Bildik, Ha-Neul Kim, et al.
Nature Communications|January 16, 2019
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformationYoshihito Kano, Teklab Gebregiworgis, Christopher B Marshall, et al.
Pageof 7